Newsletters

Announcement of New Management Structure

Announcements for products

Announcement of the start of Phase III clinical trials of IK-01 for the treatment of osteoarthritis of the knee

Newsletters

Company Name Change and Headquarters Relocation

Company information

Strategic Agreement with FBRI for R&D and Manufacturing Advancement

Company information

Completion of Series C Financing of JPY 2.38 Billion

Newsletters

Announcement on the conclusion of a joint development agreement

Newsletters

Announcement on launch of Sakracy

Company information

Announcement on change of representative director

Company information

Announcement on year-end and new year holidays

Newsletters

Announcement on capital and business alliance with the Cyberdyne group